Registered Kenya · PPB

LOCABIOTAL SOLUTION FOR ORAL HEALTH

FUSAFUNGINE 1% W/V.

What it does

Fusafungine is a medicine used to treat infections in the throat and lungs caused by bacteria.

Commonly used for: throat infections, lung infections, bacterial infections

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
584
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
FUSAFUNGINE 1% W/V.
Strength
-
Pack size
-
Therapeutic class
-
ATC class (WHO)
R02AB - Antibiotics
Drug group
RESPIRATORY SYSTEM
RxNorm RxCUI
25437
Manufacturer / MAH
Harleys
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
63 Westlands Rd, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:51:45 · updated 2026-07-26 11:42:15

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Fusafungine is a medicine used to treat infections in the throat and lungs caused by bacteria.

What it treats

  • throat infections
  • lung infections
  • bacterial infections

How it works

Fusafungine works by killing bacteria that cause infections in the respiratory system.

Who it's for

This medicine is for adults and children with bacterial infections in the throat or lungs.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: fusafungine

BNF-referenced

Fusafungine is an anti-inflammatory and antimicrobial agent used primarily in the treatment of respiratory tract infections. It exhibits both local and systemic effects, making it useful in managing conditions associated with inflammation and infection in the respiratory system.

Indications

  • Acute bronchitis
  • Chronic obstructive pulmonary disease (COPD) exacerbations
  • Sinusitis
  • Pharyngitis

Dosage

Children: Refer to the BNF for Children for age-specific dosing recommendations.

Adults: Refer to specific product guidelines for dosing according to condition and severity. Dosage may vary based on clinical judgment.

Mechanism of action

Fusafungine works by inhibiting the synthesis of certain proteins in bacteria, leading to a bacteriostatic effect. It also exerts anti-inflammatory properties, reducing swelling and irritation in the respiratory tract, thereby alleviating symptoms associated with infections.

Pharmacodynamics

Fusafungine has a dual action: it acts as an antimicrobial agent against a variety of pathogens, primarily those that cause respiratory infections, and it also reduces inflammation. The anti-inflammatory effects contribute to symptomatic relief in respiratory conditions, enhancing patient comfort.

Pharmacokinetics

Fusafungine is administered via inhalation, which allows for direct delivery to the respiratory tract. It is rapidly absorbed in the lungs, where it exerts its therapeutic effects. The drug is metabolized in the body, though specific metabolic pathways are not well characterized. Elimination half-life and excretion routes are not readily available, indicating a need for further research on its pharmacokinetic profile.

Contra-indications

  • Hypersensitivity to fusafungine or any excipients.
  • History of asthma or bronchospasm.

Adverse effects

  • Local irritation at the site of application.
  • Allergic reactions such as rash or urticaria.
  • Bronchospasm.

Precautions

  • Use with caution in patients with a history of respiratory disorders.
  • Monitor patients for signs of allergic reactions.

Pregnancy

Limited data on the use of fusafungine in pregnant women. Use only if clearly needed.

Breast-feeding

Limited data available. Caution is advised; consult a healthcare professional.

Storage

Store at room temperature, away from direct sunlight and moisture.

Formulations

  • Aerosol spray.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: fusafungine

PubChem CID 3084092

Molecular formula: C33H57N3O9

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.